[The use of cephmetazon in treating infectious inflammatory diseases of the upper and lower urinary tract]

A clinical trial of cephmethasone (Sankyo, Japan) has been performed in 40 patients with pyelonephritis. 3 patients with chronic cystitis. 19 patients with chronic prostatitis. Cephmethasone, cephalosporin of the second generation, is active against gram-positive and gram-negative agents, hospital infection. The treatment course consists of 4-14 daily doses of 2-4 g. Bacterial elimination was reached in 79.5% of the cases with a complete response in 70% and partial one in 30% of patients. Side effects were not registered. As a highly active wide-spectrum antibiotic, cephmethasone is offered for treatment of urinary infections. Cephmethasone monotherapy provides a rapid relief of cystitis, prostatitis and pyelonephritis symptoms.